Delivery Order SPE2DB24D1205-SPE2DB25FCYZN
- Not listed
- The Defense Logistics Agency (DLA) awarded a $1,479.44 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Methylphenidate ER 36 mg tablets in a quantity of 100 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,073.04 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100-count units). This order, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a firm fixed-price, competitively awarded contract with no set-aside designation. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,304.90 to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100-count bottles), with a completion date of September 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The place of performance is located at the contractor's corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,690.77 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) on July 30, 2025, with completion scheduled for July 31, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order falls under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,382.19 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100-count bottles) with an ultimate completion date of September 19, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply framework with the federal government. The product will be delivered to the company's facility...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,318.60 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100 count units). The contract is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 31, 2025, awarded on July 30, 2025. AmerisourceBergen Drug Corp will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $1,296.30 delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100-count bottles) with an ultimate completion date of July 1, 2025. This is a firm fixed-price, non-set-aside contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026. The product will be delivered to AmerisourceBergen's facility...
- The Defense Logistics Agency awarded a delivery order valued at $1,565.88 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100 count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be performed and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Methylphenidate ER 36 mg tablets (100 count) with a ceiling value of $2,544.82. This is a firm fixed-price delivery order with no set-aside designation, executed competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026. The product will be delivered to the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,656.40 to AmerisourceBergen Drug Corp for Methylphenidate ER(LA) 10mg tablets (100 count). The contract is a firm fixed price delivery order with an ultimate completion date of June 2, 2025, and was awarded on May 30, 2025, with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction within the...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCYZNDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,017.91 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets in quantities of 100 units. This is a firm fixed price, non-set-aside competitive award with a performance location in Conshohocken, Pennsylvania, and an ultimate completion date of July 30, 2025. The delivery order was issued on July 29, 2025, under AmerisourceBergen's existing contract vehicle with DLA. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at approximately $1 billion through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, supplying an extensive portfolio of medications and medical supplies to support military and veteran healthcare systems. The company's federal contract portfolio demonstrates its capability to meet diverse medical supply requirements through competitive procurement, with delivery orders ranging from minimal to substantial values across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 7/29/25 |